REMEDi4ALL is pleased to announce that the MOI‑A study, one of the REMEDi4ALL demonstrator projects,…
tools@teamitresearch.com14 January 2026
This Forbes article highlights iDR25 (the International Drug Repurposing Conference) and the growing potential of drug repurposing to expand treatment possibilities in rare diseases.
REMEDi4ALL features in a New York Times article on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
You can unsubscribe at any time.
You can unsubscribe at any time.